Lyell Immunopharma shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $134k | 97k | 1.38 |
| 2024-06-30 | $141k | 97k | 1.45 |
| 2024-03-31 | $1.5M | 655k | 2.23 |
| 2023-12-31 | $315k | 163k | 1.94 |
| 2023-09-30 | $374k | 255k | 1.47 |
| 2023-06-30 | $749k | 235k | 3.18 |
| 2023-03-31 | $1.5M | 625k | 2.36 |
| 2022-12-31 | $2.0M | 572k | 3.47 |
| 2022-06-30 | $3.4M | 527k | 6.52 |
| 2022-03-31 | $2.6M | 518k | 5.05 |
| 2021-12-31 | $3.6M | 464k | 7.74 |